All Relations between mog and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
Getaw Worku Hassen, Jason Feliberti, Leo Kesner, Alfred Stracher, Foroozan Mokhtaria. Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain research. vol 1236. 2009-04-16. PMID:18725211. here we evaluated markers of axonal injury (amyloid precursor protein, na(v)1.6 channels), neuronal calpain content and the effect of cyla on axonal protection using histological methods in chronic eae [myelin oligodendrocyte glycoprotein (mog)-induced disease model of ms]. 2009-04-16 2023-08-12 mouse
Joel A Black, Stephen G Waxma. Phenytoin protects central axons in experimental autoimmune encephalomyelitis. Journal of the neurological sciences. vol 274. issue 1-2. 2009-04-09. PMID:18485368. here we discuss studies in our laboratory that examined the protective effects of phenytoin, a well-characterized sodium-channel blocker, in the inflammatory/demyelinating disorder experimental autoimmune encephalomyelitis (eae), a model of ms. administration of phenytoin to c57/bl6 mice inoculated with rat myelin oligodendrocyte glycoprotein (mog) provides improved clinical status, preservation of axons, enhanced action potential conduction and reduced immune infiltrates compared to untreated mice with eae. 2009-04-09 2023-08-12 mouse
Camille J Olechowski, Janet J Truong, Bradley J Ker. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain. vol 141. issue 1-2. 2009-04-08. PMID:19084337. we show here that female c57bl/6 mice immunized with myelin oligodendrocyte glycoprotein (mog(35-55)) develop a robust allodynia to both cold and tactile stimuli. 2009-04-08 2023-08-12 mouse
Patrice H Laliv. Autoantibodies in inflammatory demyelinating diseases of the central nervous system. Swiss medical weekly. vol 138. issue 47-48. 2009-03-31. PMID:18951202. one of the most intensively studied antigen targets in ms is a glycoprotein of the myelin sheath called the myelin oligodendrocyte glycoprotein (mog). 2009-03-31 2023-08-12 Not clear
Matthias Bros, Nadine Wiechmann, Verena Besche, Timo Castor, Stephan Sudowe, Stephan Grabbe, Angelika B Reske-Kun. A novel plasmid DNA electroporation method allows transfection of murine DC. Journal of immunological methods. vol 343. issue 1. 2009-03-31. PMID:19186183. however, stimulated transfected bm-dc pulsed with myelin oligodendrocyte protein (mog)-derived peptide induced proliferation of mog-reactive cd4(+) t cells as potently as did non-transfected mog peptide-pulsed bm-dc. 2009-03-31 2023-08-12 Not clear
Yossan-Var Tan, Catalina Abad, Robert Lopez, Hongmei Dong, Shen Liu, Alice Lee, Rosa P Gomariz, Javier Leceta, James A Wasche. Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 6. 2009-03-10. PMID:19190179. here, we subjected pacap-deficient mice to myelin oligodendrocyte glycoprotein (mog(35-55))-induced eae. 2009-03-10 2023-08-12 mouse
Luciana Nogaroli, Larra M Yuelling, Jameel Dennis, Karen Gorse, Shawn G Payne, Babette Fus. Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes. Neurochemical research. vol 34. issue 1. 2009-02-23. PMID:18594965. this effect was associated by an increase in the mrna levels coding for mbp but not myelin oligodendrocyte glycoprotein (mog). 2009-02-23 2023-08-12 Not clear
Hui-Rong Jiang, Zakeya Al Rasebi, Eric Mensah-Brown, Allen Shahin, Damo Xu, Carl S Goodyear, Sandra Y Fukada, Fu-Tong Liu, Foo Y Liew, Miodrag L Luki. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950). vol 182. issue 2. 2009-02-19. PMID:19124760. we have investigated the functional role of gal-3 in experimental autoimmune encephalomyelitis (eae) following immunization with myelin oligodendrocyte glycoprotein (mog)35-55 peptide. 2009-02-19 2023-08-12 mouse
F Fazio, S Notartomaso, E Aronica, M Storto, G Battaglia, E Vieira, S Gatti, V Bruno, F Biagioni, R Gradini, F Nicoletti, R Di Marc. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis. Neuropharmacology. vol 55. issue 4. 2009-02-06. PMID:18619983. eae was induced in mice by immunization with the 35-55 fragment of mog (myelin oligodendrocyte glycoprotein). 2009-02-06 2023-08-12 mouse
Ruth Huizinga, Wouter Gerritsen, Nicole Heijmans, Sandra Amo. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiology of disease. vol 32. issue 3. 2009-01-28. PMID:18804534. recently, we have demonstrated that autoimmunity to the axonal/neuronal cytoskeletal protein neurofilament light (nf-l) induces axonal damage and neurological disease including spasticity - a common feature of ms. to examine the relationship between axonal damage and demyelination we have characterized the detailed neuropathology of nf-l-induced disease in biozzi mice compared to classical experimental autoimmune encephalomyelitis (eae) induced with myelin oligodendrocyte glycoprotein (mog). 2009-01-28 2023-08-12 mouse
Joel N H Stern, Derin B Keski. Strategies for the identification of loci responsible for the pathogenesis of multiple sclerosis. Cellular & molecular biology letters. vol 13. issue 4. 2008-12-29. PMID:18726192. self reactive cd4+ t cells, specific for cns antigens, such as myelin basic protein (mbp), myelin oligodendrocyte glycoprotein (mog) and proteolipid protein (plp), are detectable in ms patients along with pathogenic autoantibodies specific to these cns antigens produced by b cells. 2008-12-29 2023-08-12 Not clear
James Chan, Ee Jun Ban, Keng Hao Chun, Shunhe Wang, B Thomas Bäckström, Claude C A Bernard, Ban-Hock Toh, Frank Alderucci. Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. Journal of immunology (Baltimore, Md. : 1950). vol 181. issue 11. 2008-12-29. PMID:19017946. here we have tested this hypothesis in experimental autoimmune encephalomyelitis (eae) induced by the self-ag myelin oligodendrocyte glycoprotein (mog). 2008-12-29 2023-08-12 mouse
Asa Andersson, Magnus Isaksson, Judit Wefer, Anna Norling, Amilcar Flores-Morales, Fredrik Rorsman, Olle Kämpe, Robert A Harris, Anna Lobel. Impaired autoimmune T helper 17 cell responses following DNA vaccination against rat experimental autoimmune encephalomyelitis. PloS one. vol 3. issue 11. 2008-12-23. PMID:18997868. we have previously shown that vaccination with dna encoding the encephalitogenic peptide myelin oligodendrocyte glycoprotein (mog)(91-108) (pmog) suppresses mog(91-108)-induced rat experimental autoimmune encephalomyelitis (eae), a model for human multiple sclerosis (ms). 2008-12-23 2023-08-12 human
Sherry S Smith, Michael Ludwig, Jillian E Wohler, Daniel C Bullard, Alex J Szalai, Scott R Barnu. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice. Neuroscience letters. vol 442. issue 2. 2008-12-12. PMID:18634851. in these studies we demonstrated that myelin oligodendrocyte glycoprotein (mog)-induced eae is markedly attenuated in both icam-1(-/-) and c3(-/-) mice. 2008-12-12 2023-08-12 mouse
Heather A Wasserman, Carrie D Beal, Yan Zhang, Ning Jiang, Cheng Zhu, Brian D Evavol. MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1. Journal of immunology (Baltimore, Md. : 1950). vol 181. issue 10. 2008-12-12. PMID:18981103. the mhc variant peptide of myelin oligodendrocyte glycoprotein (mog)(35-55) proves an effective treatment as it does not induce symptoms of experimental autoimmune encephalomyelitis and fails to recruit macrophages or mog(35-55)-specific t cells to the cns. 2008-12-12 2023-08-12 mouse
Jane A Atwood, Bernd H A Reh. Protein engineering towards biotechnological production of bifunctional polyester beads. Biotechnology letters. vol 31. issue 1. 2008-12-05. PMID:18800192. the polyester synthase and the phasin protein were fused to the green fluorescent protein (gfp) and the murine myelin oligodendrocyte glycoprotein (mog), respectively, or gfp and mog were fused to the n- and c-terminus, respectively, of only the phasin. 2008-12-05 2023-08-12 Not clear
Ellen Gielen, Nick Smisdom, Ben De Clercq, Martin Vandeven, Rik Gijsbers, Zeger Debyser, Jean-Michel Rigo, Johan Hofkens, Yves Engelborghs, Marcel Ameloo. Diffusion of myelin oligodendrocyte glycoprotein in living OLN-93 cells investigated by raster-scanning image correlation spectroscopy (RICS). Journal of fluorescence. vol 18. issue 5. 2008-12-04. PMID:18204890. here, we report on the first investigations of the diffusion behavior of the myelin-specific protein mog (myelin oligodendrocyte glycoprotein) in oln-93 as studied by the recently developed rics (raster-scanning image correlation spectroscopy) technique. 2008-12-04 2023-08-12 Not clear
Nico Melzer, Sven G Meuth, Delany Torres-Salazar, Stefan Bittner, Alla L Zozulya, Christian Weidenfeller, Alexandra Kotsiari, Martin Stangel, Christoph Fahlke, Heinz Wiend. A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PloS one. vol 3. issue 9. 2008-11-25. PMID:18773080. in order to identify pathways to dampen excitotoxic inflammatory cns damage, we assessed the effects of a beta-lactam antibiotic, ceftriaxone, reported to enhance expression of glial eaat2, in "myelin oligodendrocyte glycoprotein" (mog)-induced eae. 2008-11-25 2023-08-12 mouse
H Wang, K L Munger, M Reindl, E J O'Reilly, L I Levin, T Berger, A Ascheri. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology. vol 71. issue 15. 2008-10-31. PMID:18753473. it remains uncertain whether the presence of serum anti-myelin oligodendrocyte glycoprotein (mog) antibodies in healthy individuals contributes to predict their risk of developing multiple sclerosis (ms). 2008-10-31 2023-08-12 Not clear
M V Jones, T T Nguyen, C A Deboy, J W Griffin, K A Whartenby, D A Kerr, P A Calabres. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 199. issue 1-2. 2008-10-14. PMID:18582952. we measured inflammatory and neural markers of disease from 7 days to one year after induction of experimental autoimmune encephalomyelitis (eae) by immunization with myelin oligodendrocyte glycoprotein (mog) peptide. 2008-10-14 2023-08-12 Not clear